High-Risk Brain Research Wins NSF Backing
By Sara Reardon,
Nature News
| 08. 18. 2014
The National Science Foundation's (NSF’s) role in the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative is starting to take shape. On 18 August, the NSF awarded 36 grants totalling US$10.8 million to projects studying topics ranging from electrodes that measure chemical and electrical signals to artificial-intelligence programs that can identify brain structures.
The three agencies participating in the BRAIN Initiative have taken markedly different approaches. The Defense Advanced Research Projects Agency, which received $50 million this year for the neuroscience initiative, is concentrating on implants and treatments for brain disorders that affect soldiers and veterans, such as post-traumatic stress disorder. It has already awarded multi-million dollar grants to several teams. The National Institutes of Health (NIH), which received $40 million this year, has put together a 146-page plan to map and observe the brain over the next decade, and will announce its first round of grant recipients next month.
The NSF, by contrast, has cast a wider net. The agency sent a request in March for informal, two-page project ideas. The only criterion was that the projects somehow address...
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/
Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...
